Hosted on MSN13d
HMPV vs other respiratory viruses: Is it similar to Covid-19, influenza, and RSV?
Human metapneumovirus (hMPV) cases continue to be reported in several states across India, although the number of cases is ...
clinicaltrialsarena1d
Inhalon launches human challenge trial for RSV treatment
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
WWMT Grand Rapids/Lansing on MSN3d
'Quad-demic' hitting the U.S. with four respiratory illnesses on the rise
It’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...
Managed Healthcare Executive13d
A Look at Human Metapneumovirus — a Respiratory Virus You've Likely Had Without Knowing
Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...
Virus spreading in China raises concerns in the United States
A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.
GlobalData on MSN5d
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.
The lesser-known winter virus that is different to flu and Covid but just as dangerous
Human metapneumovirus (hMPV) has been hitting the headlines recently as one of the lesser-known winter illnesses that can ...
hVIVO wins contract for RSV drug human trial for Inhalon Biopharma
(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...